TFDA Approves the First Autonomous Neurosurgical Navigation Robot, NaoTrac, from Brain Navi Biotechnology ...Middle East

HSINCHU, Aug. 7, 2022 /PRNewswire/ -- NaoTrac, the CE-certified neurosurgical navigation robot, achieved approval from Taiwan's Food and Drug Administration (TFDA) in July 2022, and is planned for submission to the FDA (U.S. Food and Drug Administration) for clearance by the end of 2022....

Hence then, the article about tfda approves the first autonomous neurosurgical navigation robot naotrac from brain navi biotechnology was published today ( Monday 08/08/2022 - 03:04 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( TFDA Approves the First Autonomous Neurosurgical Navigation Robot, NaoTrac, from Brain Navi Biotechnology )

Also on site :

• Annum Capital and Turoid - Unlocking AI for Asia Family Offices
• Best VPN (January 2026): Webroot Named Top Secure Browsing and Privacy Tool by Software Experts
• Calling All STEM Students: Apply for PG&E College Scholarships of Up to $10,000